Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about DMT Clinical Trial

Recent news which mentions DMT Clinical Trial

Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
Tickers ATAI
Tags DMT/Assisted Therapy Srinivas Rao VLS/01
From Benzinga
Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
Tickers CYBN NEWS
Tags News CYBN Management
From Benzinga
Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics
Tickers CYBN DMTTF
Tags Benzinga DMTTF Psychedelic/Assisted Therapies
From Benzinga
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
Tickers ATAI
Tags Markets ATAI Management
From Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
Tickers CYBN
Tags Cannabis Market News Benzinga
From Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
Tickers CYBN DMTTF
Tags Cannabis Market News Drug Interactions
From Benzinga
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
Tickers CYBN DMTTF
Tags CYBN M&A Short/Acting Psychedelics
From Benzinga
Cybin Launches 3-Day Overnight Public Offering For Up To $8.25M, Suspends Prior Purchase Deal
Tickers CYBN IPOS
Tags Psychedelics CYBN News
From Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
Tickers AGNPF
Tags Markets Management Human Stroke
From Benzinga
Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes
Tickers CYBN
Tags DMT Entities Psychedelics CYBN
From Benzinga
Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
Tickers ATAI CMPS
Tags Psychedelics Small Cap DMT Clinical Trial
From Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
Tickers DMTTF
Tags Psychedelics major depressive disorder Market News
From Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
Tickers AGNPF
Tags DMT Clinical Trial Penny Stocks Benzinga
From Benzinga
Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial
Tickers BMNDF
Tags Drug Delivery Technologies BMNDF Psychedelics
From Benzinga
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
Tickers AGNPF
Tags Psychedelics Yale University Penny Stocks
From Benzinga
atai's Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing
Tickers ATAI
Tags Psychedelics ATAI treatment/resistant depression
From Benzinga
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
Tickers BMNDF
Tags Benzinga Penny Stocks DMT Clinical Trial
From Benzinga
A Deeper Look At DMT Trials & Studies
Tickers DMT
Tags Psychedelics Cannabis Markets
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.